Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Miglitol is the first Glycoside hydrolase / Alfa-glucosidase inhibitor that helps to smooth out the peak plasma glucose levels after meals, thereby improving glycaemic control. This improvement is evident in the reduction of glycosylated haemoglobin (HbA1c) levels. As an oral antihyperglycaemic agent, it is prescribed for the treatment of patients with type 2 diabetes mellitus.
In the context of Miglitol & Type 2 diabetes (T2D), miglitol is an FDA-approved oral [alfa-glucosidase inhibitor](brain://bwmWuy6qSE23C9G…